[1]
‘Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study’, AJBR, vol. 22, nr. 3, pp. 347–352, dec. 2019, Geraadpleegd: 5 april 2026. [Online]. Beschikbaar op: https://ojshostng.com/index.php/ajbr/article/view/1335